R. Motzer, M. Mazumdar, J. Bacik, W. Berg, A. Amsterdam et al., Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma, J Clin Oncol. J Clin Oncol. J Clin Oncol, vol.175, issue.2122, pp.2530-2570, 1999.

V. Bolanos-garcia, Aurora kinases, The International Journal of Biochemistry & Cell Biology, vol.37, issue.8, pp.1572-1579, 2005.
DOI : 10.1016/j.biocel.2005.02.021

Y. Jeng, S. Peng, C. Lin, H. Hsu, J. Aurora-a-in-hepatocellular-carcinoma-bischoff et al., A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast Aurora A and B kinases as targets for cancer: will they be selective for tumors? Expert Rev Anticancer Ther, Clin Cancer Res. Embo J. Cancer Epidemiol Biomarkers Prev, vol.109, issue.6, pp.2065-71, 1998.

P. Carpinelli and J. Moll, Is there a future for Aurora kinase inhibitors for anticancer therapy?, Curr Opin Drug Discov Devel, vol.12, issue.4, pp.533-575, 2009.

B. Bassil, D. Dosoretz, G. Prout, and J. , Validation of the tumor, nodes and metastasis classification of renal cell carcinoma, J Urol, vol.134, pp.450-454, 1985.

R. Giet, C. Petretti, and C. Prigent, Aurora kinases, aneuploidy and cancer, a coincidence or a real link?, Trends in Cell Biology, vol.15, issue.5, pp.241-50, 2005.
DOI : 10.1016/j.tcb.2005.03.004

URL : https://hal.archives-ouvertes.fr/inserm-00966568

S. Rojanala, H. Han, R. Munoz, W. Browne, R. Nagle et al., The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer, Mol Cancer Ther, vol.3, pp.451-458, 2004.

T. Gritsko, D. Coppola, J. Paciga, L. Yang, M. Sun et al., Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer, Clin Cancer Res, vol.9, pp.1420-1426, 2003.

P. Chieffi, L. Cozzolino, A. Kisslinger, S. Libertini, S. Staibano et al., Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation, The Prostate, vol.90, issue.3, pp.326-359, 2006.
DOI : 10.1002/pros.20345

S. Sen, H. Zhou, R. Zhang, D. Yoon, F. Vakar-lopez et al., Amplification/Overexpression of a Mitotic Kinase Gene in Human Bladder Cancer, CancerSpectrum Knowledge Environment, vol.94, issue.17, pp.1320-1329, 2002.
DOI : 10.1093/jnci/94.17.1320

T. Cha, M. Chuang, S. Wu, G. Sun, S. Chang et al., Dual Degradation of Aurora A and B Kinases by the Histone Deacetylase Inhibitor LBH589 Induces G2-M Arrest and Apoptosis of Renal Cancer Cells, Clinical Cancer Research, vol.15, issue.3, pp.840-50, 2009.
DOI : 10.1158/1078-0432.CCR-08-1918

J. Cheville, C. Lohse, and H. Zincke, Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma, The American Journal of Surgical Pathology, vol.27, issue.5, pp.612-624, 2003.
DOI : 10.1097/00000478-200305000-00005

J. Patard, E. Leray, N. Rioux-leclercq, L. Cindolo, V. Ficarra et al., Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience, Journal of Clinical Oncology, vol.23, issue.12, pp.2763-71, 2005.
DOI : 10.1200/JCO.2005.07.055